Literature DB >> 2745760

Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis.

E W Monroe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2745760     DOI： 10.1016/s0190-9622(89)80353-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

Review 1.  Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions.

Authors:  Antoinette I M van Laarhoven; Ineke M van der Sman-Mauriks; A Rogier T Donders; Mathilde C Pronk; Peter C M van de Kerkhof; Andrea W M Evers
Journal:  J Invest Dermatol       Date:  2014-12-01       Impact factor: 8.551

Review 2.  Pruritus and atopic dermatitis.

Authors:  Ulf Darsow; Florian Pfab; Michael Valet; Johannes Huss-Marp; Heidrun Behrendt; Johannes Ring; Sonja Ständer
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 3.  Management of itch in atopic dermatitis.

Authors:  Judith Hong; Joerg Buddenkotte; Timothy G Berger; Martin Steinhoff
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 4.  Therapy of pruritus.

Authors:  Tejesh Patel; Gil Yosipovitch
Journal:  Expert Opin Pharmacother       Date:  2010-07       Impact factor: 3.889

5.  [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].

Authors:  A Brune; D Metze; T A Luger; S Ständer
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

Review 6.  [Pruritus in atopic dermatitis-comparative evaluation of novel treatment approaches].

Authors:  Svenja Müller; Felix Witte; Sonja Ständer
Journal:  Dermatologie (Heidelb)       Date:  2022-06-10

Review 7.  Pruritus: a practical approach.

Authors:  P J Greco; J Ende
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

8.  Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.

Authors:  K Kasutani; E Fujii; S Ohyama; H Adachi; M Hasegawa; H Kitamura; N Yamashita
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus.

Authors:  Jungsoo Lee; Jung U Shin; Seongmin Noh; Chang Ook Park; Kwang Hoon Lee
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

10.  Mild exercise suppresses exacerbation of dermatitis by increasing cleavage of the β-endorphin from proopiomelanocortin in NC/Nga mice.

Authors:  Keiichi Hiramoto; Hiromi Kobayashi; Atsuo Sekiyama; Eisuke F Sato; Daisuke Tsuruta; Masamitsu Ishii
Journal:  J Clin Biochem Nutr       Date:  2012-11-20       Impact factor: 3.114
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.